Coalition for Life Course Immunisation’s Post

Did you know? Spain is leading the way by becoming one of the first countries to introduce RSV immunisation with Nirsevimab for infants, showcasing the potential of proactive vaccination strategies. 💡 This proves that proactive vaccination policies work — but why aren’t they adopted widely? Across Europe, low vaccine budgets hinder progress, with most countries investing less than 0.5% of healthcare funds in immunisation. 📊 Discover how Spain's approach can inspire life-course immunisation across the region. Read the full report ⬇️

Life-course immunisation plays a crucial role in reducing disease burden, lowering healthcare costs, and promoting economic stability. 📉💉 Discover the key steps needed to build a resilient healthcare model in this insightful report, produced in collaboration with our client. 📊🏥

📊 Don’t miss our recent report on adult vaccination strategies in Europe! It underscores the essential role of life-course immunisation in enhancing public health outcomes. Explore the key insights and recommendations here: 🔗https://lnkd.in/ep_X4SGQ

Honored to be part of the #ICID2024 symposium "Prioritizing prevention through life course vaccination is essential to reduce the burden of respiratory diseases" in Cape Town this week. https://lnkd.in/gniDzF2c Vaccines play a pivotal role in protecting individuals across all ages, from infancy to older adulthood. Implementing a robust vaccination strategy helps reduce hospitalizations, healthcare costs, and disease transmission, while enhancing overall quality of life. Targeted vaccination programs can shield vulnerable populations, such as older adults and those with chronic conditions, from severe outcomes. In fact according to a report from the Office of Health Economics, adult vaccines can return up to 19 times their initial investment to society, when their significant benefits beyond the healthcare system are monetized. https://shorturl.at/KViQt By promoting vaccine uptake at key life stages, we build resilient communities and relieve healthcare systems. Investing in life course vaccination is a proactive approach to healthier populations and sustainable healthcare. #VaccinesWork #LifeCourseVaccination #PublicHealth #Prevention #Immunization #HealthyAgeing #AdultVaccination #HealthEconomics

The respiratory syncytial virus (RSV) vaccine is recommended for immunocompromised individuals aged 60 and above despite limited data. In an electronic health records-based observational study that included over 10,000 predominantly mild to moderately immunocompromised individuals ≥60 year olds, vaccine effectiveness was 73 percent against RSV-associated hospitalization at follow-up of one year. This study supports vaccination against RSV in immunocompromised individuals aged 60 and above. Stay #UpToDate with What's New in #InfectiousDiseases: https://ow.ly/VsNM50UebZr #ClinicalUpdates #meded

Vaccine effectiveness data are crucial to understanding the value of vaccines for improving patient care and outcomes. Invasive pneumococcal disease remains a risk for many people. Guideline-based immunization is an important clinical tool for decreasing that risk. #PFEColleague

This week we celebrate World Immunization Week, a World Health Organization initiative dedicated to highlighting the collective action needed to protect people from vaccine-preventable diseases. 💉 Vaccines play a key role in protecting public health, helping to prevent the spread of deadly diseases and saving countless lives around the world. This week marks the 50th anniversary of EPI, and serves as an important reminder for the ongoing need for of more vaccine Research & Development and improved access across the globe. As a CDMO working to supply pioneers at the forefront of these efforts with the raw materials and expertise they need, we proudly support the ongoing work to bring more vaccines to life and improve healthcare outcomes for all. Learn more about the building blocks of life we supply. 👇 https://loom.ly/cRJAk3g #mRNA #WorldVaccineWeek2024 #WVW24 #CDMO

This month, we celebrate the remarkable achievements of immunisation in advancing public health. Vaccines have been instrumental in eradicating diseases, preventing outbreaks, and enhancing quality of life across the United States. Here are a few highlights: 🔬 Innovation in Vaccines: Ongoing research and development are leading to more effective and accessible vaccines, tackling both existing and emerging diseases. 🏆 Public health Milestones: Vaccination programmes have significantly reduced the incidence of diseases like measles and polio, showcasing the power of collective health efforts. 🌍 Global impact: US-led initiatives are supporting vaccination campaigns worldwide, contributing to global health security and disease prevention. This National Immunisation Awareness Month, let’s acknowledge these achievements and continue advocating for the importance of vaccines in protecting our communities. #NIAM2024 #VaccinesWork #PublicHealth #HealthcareInnovation #GlobalHealth #Immunisation #HealthAchievements

Featured Research article from our latest JFMB 2nd issue Vol.66 concludes that: ATPase and GTPase levels are increased in patients with fibrotic lung disease regardless of the COVID-19 vaccination state.  https://lnkd.in/exwueyZZ

Featured Research article from our latest JFMB 2nd issue Vol.66 concludes that: ATPase and GTPase levels are increased in patients with fibrotic lung disease regardless of the COVID-19 vaccination state.  https://lnkd.in/eXht7VDZ